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Abstract 
Background and Aims 
Idiopathic intracranial hypertension (IIH) is a clinical syndrome of intracranial 
hypertension with normal cerebrospinal fluid in the absence of a mass lesion or 
hydrocephalus on brain imaging. Headache is the most common symptom of IIH, and 
about10-15% of patients suffer irreversible visual impairment. Previous estimates of 
the annual incidence of IIH vary world-wide from 0.03-2.2 per 100,000. The major 
risk factor implicated in IIH is body mass. Scotland has one of the worst records for 
obesity in the developed world and the prevalence of obesity in Fife is significantly 
higher than the Scottish average. Our aim was to record the incidence of IIH in NHS 
Fife over a one year period. 
Methods and Results 
Prospective study including every patient that was seen in the ophthalmology 
department in NHS Fife with a new diagnosis of IIH over a one year period.  
Thirteen patients were seen with a new diagnosis of IIH from August 2013 to July 
2014 giving an incidence of 3.56 per 100 000. Headache was the most common 
presenting symptom. Three patients were asymptomatic but were noted to have 
swollen optic discs during a routine sight test. One patient complained of visual 
symptoms. All patients were overweight. The mean BMI was 36 (range 28-49) 
Conclusion 
The incidence of IIH in NHS Fife was between 2 and 4 times higher than previous 
estimates in the literature. This is probably due to a high level of obesity in Fife. 
Scotland is in the midst of an obesity epidemic and if this continues we may see 
increasing levels of IIH nationally with associated increasing incidence of visual 
impairment in young adults. 
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Introduction 
Idiopathic intracranial hypertension (IIH) is a clinical syndrome of intracranial 
hypertension with normal cerebrospinal fluid (CSF) in the absence of a mass lesion or 
hydrocephalus on brain imaging. Its aetiology is unknown, and in adults it classically 
affects young women of childbearing age. Diagnosis is made based on the Modified 
Dandy Criteria1 (table 1) and the clinical features, risk factors and natural history are 
well described in the literature2. Previous estimates of the annual incidence of IIH 
vary from 0.03-2.2 per 100,00022, apparently depending on geographical location and 
population demography. The estimated incidence in the ‘at risk’ population (women 
of childbearing age that are obese) is 3.5/100,00022. The most common symptoms of 
IIH are headache and transient visual loss. In the majority of cases, IIH is treatable, 
without impairment of vision in the long term. However, a group of patients exist who 
develop permanent visual loss, which can be rapidly progressive and devastating3,4. 
The major risk factor implicated in IIH is body mass5-8. The majority of patients with 
IIH are obese (defined as having a body mass index (BMI) of over 30) and there is 
also a link between recent weight gain and IIH. Scotland has one of the worst records 
for obesity in the developed world and the prevalence of obesity in 2012 was 
estimated at 27% in the adult population, whilst 64.3% of adults were obese or 
overweight (BMI 25-29.9)9. The prevalence of obesity in Fife is higher than the 
national average and is the fifth highest in all of the health boards in Scotland10. We 
aimed to record the incidence of IIH in NHS Fife over a period of one year. The 
population served by NHS Fife is estimated at 365,000. 
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Methods 
All new cases of IIH seen in the ophthalmology department in NHS Fife, at Queen 
Margaret Hospital and Victoria Hospital Kirkcaldy, were collected prospectively from 
August 2013 to July 2014 (1 year). Each diagnosis was made by a consultant 
ophthalmologist and a consultant neurologist. Demographic details and risk factors 
for each patient were recorded from their clinical notes. The study was run in 
accordance with the NHS Fife Quality Improvement Register. 
 
Results 
Thirteen new cases of IIH were seen in NHS Fife over the one year period giving an 
incidence of 3.56 per 100,000 patients. Twelve of these cases met all of the Modified 
Dandy Criteria (see figure 1).  The other case was a patient on anti-coagulant therapy 
for a pulmonary embolus. She presented with intermittent visual disturbance before 
developing bilateral swollen optic discs, in keeping with IIH, a week later. Cranial 
imaging showed no abnormality, however lumbar puncture was not performed 
because of the risk of bleeding. 
Twelve out of thirteen patients were female and the patients ranged from aged 17-50 
(mean age 29).  Presenting symptoms and details of the referrer were missing from 
the case notes of one patient, for whom there was also no mention of visual fields. 
Mean BMI was 36.7 (range 27-51). Six out of thirteen patients were current or ex-
smokers. Two patients were pregnant (21 and 28 weeks gestation). Headache was the 
major presenting symptom in 9 out of 12 patients. In those who had headaches one 
patient was also suffering from nausea and one patient complained of transient visual 
blurring. The other three patients were asymptomatic and had attended their optician 
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for a routine sight test. Eleven out of thirteen patients were seen by ophthalmology 
within 1 day of referral.  
At ophthalmology review twelve out of thirteen patients had a best corrected Snellen 
visual acuity of at least 6/6 in both eyes (the other patient’s vision was unchanged 
form their normal at 6/9 right and 6/18 left). None of our patients had a significant 
visual field deficit on presentation, although reliability was low in 3 tests. Twelve 
patients had optic disc swelling initially (asymmetry was noted in 4 patients) and one 
patient also had a disc haemorrhage. As mentioned above, the other patient had 
normal optic discs however was reviewed a week later because she was complaining 
of transient visual blurring. At this stage she had developed bilateral asymmetrical 
disc swelling.  
All of the patients had no significant abnormality on cranial imaging (11 with CT 
head and venogram, 2 with MRI head and venogram) and mean lumbar puncture 
opening pressure was 35cmCSF (range 26-53). CSF composition was normal in all 
cases. 
Ten patients were referred to ophthalmology by their optometrists, one by obstetrics 
and gynaecology one by their GP.  
 
Discussion 
Thirteen patients were diagnosed with IIH in Fife from July 2013 to August 2014 
giving an incidence of 3.56 per 100,000 of the population. This figure is significantly 
higher than those previously quoted in the world literature (table 2).  
With on-going improvements in complex neuroimaging the diagnostic criteria for IIH 
have undergone several modifications over the years. It is now widely accepted that 
diagnosis of IIH should be made based on the ‘modified Dandy criteria’ set out by 
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Friedman and Jacobsen in 20021. Despite these criteria, there can be pitfalls when 
diagnosing IIH (such as papilloedema vs pseudo-papilloedema). As such, the criteria 
guide a ‘best fit’ rather than a definitive diagnosis. Fotunatelely for the sake of this 
study, twelve out of thirteen of our patients met each of these criteria, whilst diagnosis 
in the other patient was made clinically as discussed above.  
The pathogenesis of IIH remains unclear, however the link between IIH and female 
sex11-13, reproductive age and obesity is established. The evidence linking IIH and 
obesity is conclusive5-8. Of the thirteen patients that we saw with a recorded BMI, ten 
(77%) were obese (range 32 – 51) and the other three (23%) were overweight (range 
27-29). Mean BMI was 36.7. Previous studies have demonstrated rates of obesity 
(BMI > 30) amongst patients with IIH to be as high as 71-91%8,12,14. One study 
estimated the mean weight of patients with IIH to be 38% above their ideal body 
weight11. There is also a link between recent weight gain and IIH, however we did not 
specifically record this in our patient group.  
Obesity is a leading cause of death and disease and its global prevalence has more 
than doubled since 1980. The World Health Organisation has described this situation 
as an “epidemic” and estimates that over 500 million adults world wide are obese and 
1.5 billion adults are either overweight or obese15. Fife has the 5th highest prevalence 
of obesity out of the 14 NHS Healthboards in Scotland, a country where obesity rates 
have increased from 17.2% in 1995 to 25.6% in 2013. It seems likely that the high 
prevalence of obesity in Fife is linked to the high incidence of IIH. Moreover, it is 
likely that other regions in Scotland, with similar levels of obesity, may have similarly 
high incidences of IIH. Further research may determine whether this is the case. 
Headache is the most common symptom of IIH (present in 10/12 of our patients) 
affecting 68-98% of patients18. However it is visual impairment, caused by ischaemic 
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damage to the optic nerve fibres, which are compressed during swelling, that is the 
main cause of morbidity. This can lead to irreversible sight loss. A British Ophthalmic 
Surveillance Unit (BOSU) study estimated that 1-2% of patients with IIH are likely to 
go blind in a given year3, but blindness rates elsewhere have been reported as high as 
10%17. Population-based surveys indicate an overall rate of visual impairment 
between 10 and 20%12,17. Visual field abnormalities, picked up on automated 
perimetry, are one of the earliest indications of optic nerve damage, with reduction of 
contrast sensitivity, colour vision and visual acuity occurring later. It is important to 
note that the grade of visual field defect does not correlate with the degree of disc 
swelling. None of our patients’ displayed signs of significant optic nerve damage on 
presentation. Other symptoms of IIH are usually reversible as intracranial pressure 
returns to normal. This includes diplopia, (present in one of our patients and caused 
by compression of the abducens nerve, as seen in raised intracranial pressure from 
other causes), ‘whooshing’ in the ear (present in one patient), nausea and vomiting 
and neck stiffness and photophobia (due to meningeal irritation). 
 
Ten out of the thirteen patients in our study were referred to the hospital eye service 
by community optometrists.  Three of these had attended their optometrist for a 
‘routine’ sight test, with no visual symptoms or headache. In 2006, new General 
Ophthalmic Services (Scotland) arrangements were introduced, delivering universally 
free comprehensive community based eye care services for the people of Scotland. 
All optometry practices were required to meet a new minimum standard, resulting in 
improvements in equipment as well as clinical skills, with the ultimate aim of 
improving referrals to the hospital eye service. The new contract has led to a change 
in what is considered to be a ‘routine sight test’, with fundal photos, visual fields and 
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fundoscopy becoming the norm. More thorough examination has led to a new group 
of asymptomatic patients being referred to the hospital eye service, of which optic 
disc, retinal and visual field abnormalities make up a large proportion16. We feel that 
this has resulted in increased numbers of patients being diagnosed with IIH despite 
being asymptomatic. These asymptomatic patients can be particularly difficult to 
manage and, with no clinical symptoms to guide management, often require more 
frequent follow-up. 
 
There are a number of questions raised by the high incidence of IIH in Fife. Would 
our findings be consistent across the other health boards in Scotland? If the current 
trend continues, will clinic capacity cope with the number of appointments needed to 
provide adequate assessment and follow-up?  Treatment of IIH is initially medical18, 
usually with oral acetazolamide, however those with acute severe visual loss, 
intractable headache or chronic progressive visual loss, not controlled by medical 
measures, require a surgical intervention to alter the flow of CSF. If successful, this 
will treat both papilloedema and headache, however complications are common and 
limit the effectiveness of these procedures19. It is well known that weight loss 
improves the course of IIH, causing resolution of symptoms and papilloedema20,21. 
Many patients struggle with this, prompting the question as to whether a more 
aggressive approach to weight loss, such as supervised dieting or bariatric surgery, 
should be made more readily available in patients with early signs of sight loss. 
Lastly, if the incidence of IIH continues to rise alongside the nation’s BMI, will we 
see an increased incidence in visual impairment and blindness amongst young 
women, with associated significant social implications? 
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The major limitations of our study might actually result in an underestimate of the 
incidence. Fife is an area in the East of Scotland with two main hospitals, Queen 
Margaret’s Hospital, Dunfermline and Victoria Hospital, Kirkaldy. Much of the local 
population works in neighbouring cities such as Edinburgh, Dundee and Stirling, all 
of which have large hospitals in other health boards. As a result, patients may present 
to a hospital outwith Fife, which may lead to an underestimation of the incidence of 
IIH in our study. As mentioned earlier it is also likely that there is a population of 
unidentified, asymptomatic individuals with IIH in the community, and our study has 
no way of identifying these individuals. This may also lead to an underestimate of the 
true incidence of IIH in Fife. Incidence studies run on the assumption that all cases 
that are seen are reported to the investigators, which is not always the case. 
Fortunately, in NHS Fife, all patients with IIH are eventually seen by the same 
consultant ophthalmologist (AB) and neurologist, who share these patients. It is 
therefore unlikely that any patients seen in NHS Fife during our study period were not 
reported. 
 
Conversely, it is possible that our study overestimates the incidence of IIH: our study 
was conducted over a one year period and this may not be representative of a long 
term incidence. That being said, when weighing this possibility against the potential 
causes of an underestimate mentioned earlier it seems more likely that our results 
favour a lower value than the true incidence. 
 
Our prospective study estimates the incidence of IIH in Fife as between 2 and 6 times 
higher than previously quoted in other UK studies. The most likely explanation for 
this high incidence is the high levels of obesity in Fife, but the improvement in fundal 
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examinations heralded by the new national optometry contract may also contribute. 
Scotland’s obesity problem is well publicised and the increased incidence of IIH 
provides further evidence of the significant adverse health implications we are starting 
to see as a consequence.  
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Table 1 
Modified Dandy Diagnostic Criteria of Idiopathic Intracranial Hypertension 
(Friedman and Jacobson, 2002) 
Signs and symptoms (if present) of increased intracranial pressure  
Intracranial pressure, as measured in the lateral decubitus position, is elevated 
The composition of the cerebrospinal fluid is normal 
There is no evidence of hydrocephalus, mass, structural or vascular lesion 
No other cause of intracranial hypertension has been identified 
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Table 2: Published studies showing the incidence of IIH in different populations (all 
significantly lower than shown in this current study). 
Year  Location  Author  Population size  IIH Incidence 
per 100,000  
1988  Iowa, USA  Durcan et al 2,913,808  0.9  
1988  Louisiana, 
USA  
Durcan et al 4,480,681  1.07  
1993  Benghazi, 
Libya  
Radhakrishnan 
et al 
519,000  2.2  
2000  Hokkaido, 
Japan  
Yabe et al 5,780,000  0.03  
2001  Belfast, N 
Ireland  
Craig et al 1,640,000  0.6  
2001  Israel  Kesler et al 5,970,000  0.75  
2004 Parma, Italy Carta et al unknown 0.28 
2011 Sheffield Raoof et al 513,234 1.56 
2014 Fife Current Study 365,000 3.56 
 
